USP20 and neoplasm: Given that CTSL has been associated with aggressive tumour phenotypes and poor prognosis in various cancers,49 our study suggests that the USP20‐STUB1‐CTSL axis may serve as a potential biomarker and therapeutic target in HNSCC.